Benaroya Research Institute

Benaroya Research Institute (BRI) is a biomedical research institute located in Seattle, Washington, United States. The institute is dedicated to advancing the understanding, prediction, prevention, and treatment of immune system diseases.

History

The Benaroya Research Institute was established in 1956 as the Virginia Mason Research Center. In 2002, it was renamed in honor of Jack Benaroya, a prominent Seattle philanthropist, after a significant donation from the Benaroya family.

Research

The institute's research focuses on autoimmune diseases, allergies, asthma, diabetes, and cancer. It is known for its work on Type 1 diabetes and rheumatoid arthritis, among other diseases. The institute employs a unique approach to research, known as the "bench to bedside" model, which aims to translate laboratory findings into clinical applications as quickly as possible.

Facilities

The Benaroya Research Institute is housed in a state-of-the-art facility in downtown Seattle. The building includes laboratories, offices, and conference rooms. The institute also houses a biorepository, which stores biological samples for use in research.

Affiliations

The Benaroya Research Institute is affiliated with the Virginia Mason Medical Center, one of the top hospitals in the United States. The institute also collaborates with other research institutions and universities around the world.

See also

• Virginia Mason Medical Center
• Autoimmune disease
• Biomedical research

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian